-
Locked Data M_2_19
Number of individuals screened for substance use (alcohol, drug use) (Medicaid) -
Locked Data M_2_18
Number of individuals with new opioid prescriptions limited to a 7-day supply -
Locked Data M_2_1_3
Number of drug overdose deaths involving any psychostimulant (including cocaine) -
Locked Data M_2_1_1
Number of drug overdose deaths involving any psychostimulant (excluding cocaine) -
Locked Data M_2_1_4
Number of drug overdose deaths involving any benzodiazepine -
Locked Data M_2_1_2
Number of drug overdose deaths involving cocaine -
Locked Data M_2_4
Number of individuals with opioid dependence or abuse (Medicaid) -
Locked Data M_2_13_c
Number of individuals with a new high-dose opioid prescribing episode, defined as ?90 mg morphine milligram equivalent (MME) over 3 calendar months -
Locked Data M_2_13_d
Number of individuals with new overlapping opioid and benzodiazepine prescriptions for at least 30 days over 3 calendar months -
Locked Data M_2_13_b
Number of individuals starting a new opioid prescribing episode with extended-release or long-acting opioid formulation -
Locked Data M_2_12_2
Number of opioid-related emergency department visits with MOUD follow-up within 31 days (Medicaid) -
Locked Data M_2_14_1
Number of naloxone units distributed through community-based programs -
Locked Data M_2_15_1
Number of individuals with OUD who are screened for hepatitis C -
Locked Data M_2_15_2
Number of individuals with OUD who are diagnosed with hepatitis C -
Locked Data M_2_15_3
Number of individuals with OUD who are treated for hepatitis C -
Locked Data M_2_16
Number of newly diagnosed HIV cases -
Locked Data Population values for HCS data analysis
There is no description for this dataset
-
Locked Data M_2_12_1
Number of individuals linked to MOUD following opioid-related emergency department visit (Medicaid) -
Locked Data M_2_13_a
Number of individuals with a new opioid prescribing episode with a duration of more than 30 days -
Locked Data M_2_13
Number of individuals with a new high-risk opioid prescribing episode (outcome measure for HCS Hypothesis 4)